Firm may have blood test to determine presence of Alzheimer's

03/15/2007 | Yahoo!

France's ExonHit Therapeutics says it has identified a set of genes that may allow it to analyze blood samples to determine if a patient has Alzheimer's disease. In one study involving a group of 85 people, the firm said, the process was able to identify 78% of the people with Alzheimer's and 82% of those without it.

View Full Article in:

Yahoo!

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Principal Engineer - Service (US/MI/00/0043/SL) - 14000009CP
Abbott
Chicago, IL
Senior Manager, Compliance
Stryker
Fremont, CA
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA